Commentary on R&D Trends Away from General Medicine/Cardiovascular Drugs: Can the FDA Help Reverse the Trend?
Meyer, RJ
Clinical pharmacology and therapeutics, 2017-08, Vol.102 (2), p.186-188
[Periódico revisado por pares]
United States
Texto completo disponível